Terminated PHASE4 INTERVENTIONAL NCT00289601

Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty

Research Evaluation to Study Individuals Who Show Thromboxane Or P2Y12 Receptor Resistance

Sponsor: Brigham and Women's Hospital

Updated 5 times since 2017 Last updated: Jul 19, 2007 Started: Mar 31, 2006 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor support withdrawn

Other terminated trials from Brigham and Women's Hospital

See all terminations from Brigham and Women's Hospital

Other Angioplasty trials with similar outcome

Browse all Angioplasty trials

Listed as NCT00289601, this PHASE4 trial focuses on Angioplasty and remains terminated or withdrawn. Sponsored by Brigham and Women's Hospital, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brigham and Women's Hospital
Schering-Plough

Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States